Data de publicação: 07/10/2020 - 15:41
In a cooperation between Fiocruz Pernambuco, the Central Laboratory of Public Health of Pernambuco (Lacen/SES-PE) and the University of Pernambuco Campus Serra Talhada (UPE-ST), a pioneer study describes the clinical and epidemiological characteristics of the first 557 patients of the state to be contaminated by the new coronavirus (SARS-CoV-2). The paper was published (29/9) in the international magazine Travel Medicine and Infectious...
Notícias
Data de publicação: 29/09/2020 - 14:00
For the first time, the Food and Drug Administration of the USA has granted the status of an orphan drug to a drug developed entirely in Brazil: the P-MAPA, immunomodulator for the treatment of schistosomiasis. P-MAPA is short for Proteic - Magnesium Ammonium Phospholinoleate Anhydride, the chemical denomination of a biopolymer produced through fermentation by the Aspergillus oryzae fungus. Researchers Juliana Carla Serafim da Silva and Bruno de...
Notícias
Data de publicação: 29/09/2020 - 10:54
In a partnership with Instituto D’Or (Idor) and the Federal University of Rio de Janeiro (UFRJ), a study by the Center for Technological Development in Health (CDTS/Fiocruz) observed that the virus responsible for the Covid-19 pandemic, the SARS-CoV-2, can infect neural cells and create brain damage. Organized by Faperj and published in preprint, the project started with the analysis of the neural tissue of a patient who died due to...
Notícias
Data de publicação: 24/09/2020 - 12:47
An international project, of which Fiocruz Pernambuco is part, is evaluating public health response to Covid-19 in Brazil, Canada, China, France, and Mali. Researchers will compare data obtained in the five countries, to identify the strong and weak points of the measures adopted, including the challenges faced by health professionals and health systems. The goal is to gather the lessons learned, based on strict interdisciplinary researches...
Notícias
Data de publicação: 24/09/2020 - 12:17
In October, Fiocruz and the Murdoch Children’s Research Institute, in Australia, will begin testing the BCG vaccine (normally used to prevent tuberculosis) on healthcare professionals, to verify the protection of the immunizer against Covid-19 as well. The trial, which was initially expected to be carried out only in the state of Mato Grosso do Sul, will be expanded to the state of Rio de Janeiro.
Coordinated in Brazil by Fiocruz...
Notícias
Data de publicação: 11/09/2020 - 15:31
The plots are astonishing. In the United States, a 14-year-old girl - still a virgin, the message highlights - supposedly became pregnant after having her flu shot. In another version of the story, the girls are Mexican and are between 11 and 17 years old. In this case, the culprit of the pregnancies is the HPV vaccine. With variations, false narratives such as these, absolutely devoid of scientific evidence, disseminate through social networks...
Notícias
Data de publicação: 11/09/2020 - 14:20
The Fiocruz Virtual Campus has announced its first course available in three languages in its platform: Healthcare in phonoaudiology - An approach on oral sensorial-motor alterations in the field of neonatology. This is an online course that focuses on phonoaudiology professionals of the Brazilian Public Health System network, additional health networks and other health professionals interested in dysphagia. This is the first course of the...
Notícias
Data de publicação: 11/09/2020 - 12:57
A research has analyzed the performance of chimeric antigens for the diagnosis of chronic Chagas disease using rapid tests. The study led by researcher Fred Luciano Neves Santos, of Fiocruz Bahia, used serum samples from different geographical regions of Brazil and from patients with different clinical presentations of the disease. The work was described in an article published in the BioMed Research International journal.
Rapid tests...
Notícias
Data de publicação: 11/09/2020 - 12:22
Researchers of Fiocruz and Visuri, reference institutions in research and development of technology for health, have developed a portable device, the OmniLAMP, for the molecular diagnosis of COVID-19 through the detection of SARS-CoV-2 genetic material. Using the RT-LAMP technique, which transforms RNA into DNA and amplifies it isothermically, the equipment makes it possible to run tests with safety levels similar to those of the PCR (polymerase...
Notícias
Data de publicação: 10/09/2020 - 12:44
The Oswaldo Cruz Foundation (Fiocruz) was selected to receive funding from Google.org, through the institution’s fund to support projects using innovative Artificial Intelligence (AI) and data analytics to help understand COVID-19 and address its impacts. The project by the Centre for Data and Knowledge Integration for Health (Cidacs/Fiocruz Bahia), with Bahia Federal University (UFBA), was one of only two selected in Brazil by Google...
Notícias
Data de publicação: 03/09/2020 - 15:21
Several patients infected with the new coronavirus (SARS-CoV-2) show an exacerbated inflammatory response caused by an exagerated activity of the patient’s immune system, in the attempt to protect the body from the pathogen. This activity is linked to significant lesions in the lungs and is one of the main factors associated to severe cases of Covid-19. To bypass this mechanism, researchers all over the world are looking for efficient ways...
Notícias
Data de publicação: 31/08/2020 - 12:47
A study by the World Mosquito Program (WMP), from the University of Monash, in Australia, in a partnership with the Tahija Foundation and the University of Gadjah Mada, in Indonesia, points to a reduction of 77% in the incidence of cases of dengue fever, virologically confirmed, in the areas where Aedes aegypti with Wolbachia were released, in Yogyakarta, Indonesia, when compared with areas that did not receive the method. This is the first gold...
Notícias
Data de publicação: 25/08/2020 - 15:19
The Oswaldo Cruz Foundation (Fiocruz), in a partnership with the Community Council of Manguinhos, Redes da Maré, Dados do Bem, SAS Brasil and União Rio, is launching an innovative project that makes possible full healthcare in the favelas, and will contribute to face the Covid-19 pandemic in the communities of Maré and Manguinhos, in Rio de Janeiro. Conexão Saúde: de olho na Covid (Health Connection: keeping an...
Notícias
Data de publicação: 25/08/2020 - 13:53
The new coronavirus pandemic has been posing unheard-of challenges to health information systems. Covid-19 data in Brazil, both at a state and municipal level, are crucial for the decision making on public policies and emergency measures to contain the pandemic. These data, however, depend on systems and panels whose coverage and quality vary wildly all over the country. This is the conclusion of a Fiocruz paper, which states that the release of...
Notícias
Data de publicação: 25/08/2020 - 13:06
Professors-researchers of the Joaquim Venâncio Polytechnic School of Health (EPSJV/Fiocruz) have launched the first bi-monthly report of the study called Health monitoring and contributions to the work processes and professional training of Community Health Agents (CHA) in times of Covid-19. The research, coordinated by Mariana Nogueira and Camila Borges, of EPSJV/Fiocruz, includes the participation of other researchers and other Fiocruz...
Notícias
Data de publicação: 25/08/2020 - 11:00
Brazilian researchers have taken the first step in the development of a simple and cheap method to disinfect surfaces and hands. Laboratory tests have shown that a film of detergent can turn inactive the aviary coronavirus (a virus that causes flu in birds and that belongs to the same family of the SARS-CoV-2, the agent of Covid-19). Based on these good results, scientists will now evaluate the action of the formula against SARS-CoV-2 in the...
Notícias
Data de publicação: 21/08/2020 - 11:19
Through its Immunobiological Technology Institute in (Bio-Manguinhos/Fiocruz), the Oswaldo Cruz Foundation is now supplying trastuzumab to the Ministry of Health (MoH), which provides it to cancer patients free of cost through the Brazilian Public Health System (SUSm in the Portuguese acronym). This is another cancer drug supplied by Bio-Manguinhos/Fiocruz, which introduced this line to its portfolio in 2020 (in addition to rituximab, for...
Notícias
Data de publicação: 21/08/2020 - 10:39
An ecological analysis on a populational basis, using data obtained from the Reportable Diseases Information System (Sinan, in the Portuguese acronym), of the Ministry of Health, was carried out with the goal of identifying an epidemiological profile of the transmission of acute Chagas disease in Brazil. Chagas disease is caused by the parasite Trypanosoma cruzi, transmitted by an insect called kissing bug, and is present in 21 countries in...
Notícias
Data de publicação: 19/08/2020 - 17:05
Fiocruz President, Nísia Trindade Lima, is the co-chair of the Group on Economic Response and Recovery of the initiative created by research funding agencies to develop a United Nations Research Roadmap for the Recovery of Covid-19. The work was commissioned by the United Nations Deputy Secretary-General, Amina Mohammed, and will be a complementary document to the UN Framework for the immediate socio-economic response to COVID-19.
The...
Notícias
Data de publicação: 17/08/2020 - 12:59
On August 4, the first debate of a cycle called Youths in Brazil: Emerging Dialogues for Health was broadcast live on the YouTube channel of Agenda Jovem Fiocruz. Marked by multidisciplinarity, the online program brings together activists, researchers from Fiocruz and other institutions, representatives of the Legislative, international agencies, universities, and project coordinators, to discuss themes regarding the health...
Notícias
Data de publicação: 17/08/2020 - 12:13
Since the confirmation of the first cases of Covid-19, Fiocruz, an institution linked to the Ministry of Health, has been working to provide responses in different areas. After developing molecular tests to detect the disease and progressively increasing their production scale, the Foundation now begins the operation of one more Support Unit to the Diagnostic of Covid-19 (click here for a virtual tour of the Unit). The initiative is...
Notícias
Data de publicação: 06/08/2020 - 17:07
The Fiocruz Global Health Center (Cris/Fiocruz), the National School of Public Health (Ensp/Fiocruz), the Network of Public Health Schools in Latin America (Resp-AL), the Latin American Alliance for Global Health (Alasag), the Argentine Network of Public Health Schools and the International Network of Health Technicians (Rets), which usually act in partnership, promoted the international seminar Vaccines and medicines for Covid-19 as global...
Notícias
Data de publicação: 06/08/2020 - 12:28
Covid-19 has shown Brazil’s fragility in promoting an industrial policy in the health area: facing the pandemic involves prevention, services preparation, drugs, equipment, diagnostic tests, and the future vaccine. When one of these parts fails the entire strategy to contain the disease’s expansion will be jeopardized. This is Carlos Gadelha’s evaluation, a researcher and coordinator of Prospection Actions at Fiocruz. “...
Notícias
Data de publicação: 05/08/2020 - 16:23
Professors and researchers may apply for the scholarships under the Institutional Internationalization Program - PrInt Fiocruz-Capes. The selection for PhDs with Experience Abroad is now reopened after a postponement due to the Covid-19 pandemic.
The call aims to attract researchers with experience in a foreign country to work at Fiocruz, whose training and professional experience represent an innovative contribution to the Fiocruz Graduate...
Notícias